Product Information
4-Phenylimidazolidin-2-one is a prodrug that is converted to an active form by hydrolysis. This compound has antiviral potency and a detection time of 1 to 4 hours. 4-Phenylimidazolidin-2-one is used as an antiviral agent for the treatment of influenza A and B. It also has anticancer activity, which may be due to its ability to inhibit allosteric binding sites on proteins such as human epidermal growth factor receptor 2 (HER2) and vascular endothelial growth factor receptor 2 (VEGFR2). It has been shown to be effective against cancer cells in vitro and in vivo, including the highly aggressive tumor cell line sw620. The mechanism of action for the anticancer activity of 4-phenylimidazolidin-2-one may be through the inhibition of protein kinase C (PKC) and phospholipase C (PLC), which are
Chemical properties
Technical inquiry about: 3D-CBA12949 4-Phenylimidazolidin-2-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
